Verified
High Ratings
80+ Specializations
210+ Therapies
Research Phase I/II/III

About Specializations

Wojskowy Instytut Medyczny Panstwowy Instytut Badawczy in Warsaw specializes in nuclear medicine and clinical trials in cancer, heart, lung, and immune diseases.

Medical Center localisation

Ul. Szaserow 128
04-141 Warsaw, Poland

Want to learn more about this study or check if you can participate? Contact us.

Ongoing studies

  • Phase 2a Study of Safety, Tolerability and Efficacy of Intranasal Cenegermin in Adults with Moderate to Severe Subacute Traumatic Brain Injury

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark Finland France Germany Italy Poland +2
  • A study to evaluate the safety and how the body uses ublituximab injections in patients with multiple sclerosis

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Poland
  • A study to evaluate the effects of BI 764198 in adults and adolescents with focal segmental glomerulosclerosis (FSGS)

    Recruiting

    3 1
    Belgium Croatia Denmark France Germany Greece +9
  • Study of Sotorasib, Panitumumab and a drug combination for patients with metastatic colorectal cancer with KRAS p.G12C mutation.

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Austria Belgium Bulgaria Czechia Denmark Estonia +12
  • Study of BNT327 and a drug combination for patients with untreated metastatic or locally recurrent triple-negative breast cancer

    Recruiting

    3 1 1
    Belgium Czechia France Germany Italy The Netherlands +2
  • A Study Testing How Well BAY 3401016 Works and How Safe It Is in Adults Aged 18 to 45 Years with Alport Syndrome

    Recruiting

    2 1
    Czechia France Germany Italy Poland Portugal +1
  • A study to evaluate the safety of dazodalibep in patients with Sjögren’s Syndrome over a long period of time

    Recruiting

    3 1 1
    Investigated Drugs:
    Belgium Croatia Denmark France Germany Greece +6
  • Study of BNT327 with etoposide and carboplatin compared to atezolizumab with etoposide and carboplatin for patients with untreated extensive-stage small-cell lung cancer

    Recruiting

    3 1 1 1
    France Germany Italy The Netherlands Poland Romania +1
  • A Study of Darovasertib Before Surgery or Radiation Therapy for Patients with Early-Stage Uveal Melanoma That Has Not Spread

    Recruiting

    3 1 1
    Investigated Drugs:
    Austria Belgium Czechia Denmark France Germany +4
  • A study testing aprepitant gel for treating skin rash in cancer patients receiving epidermal growth factor receptor inhibitor therapy

    Recruiting

    2 1
    Investigated Drugs:
    Hungary Poland Spain